Search

Experiments on rats, guinea pigs and rabbits with experimental dyslipoproteinemia have revealed that the new water-soluble high-molecular weight polymers containing digitonin (ED) or a quaternary nitrogen atom (EA) have a more marked hypolipidemic action than cholestyramine and normalize lipoprotein metabolism. The digitonin-containing enterosorbent has been shown to decrease the absorption of 4-14C-cholesterol, while the nitrogen-containing enterosorbent diminishes the absorption of 3H-cholic acid.

The bile acid sequestering agent Vasosan P is a new form of pectin-enriched cholestyramine (20%), saccharose (5%) and sorbic acid (0.18%). In comparison with cholestyramine Vasosan P has a more marked hypolipidemic effect in experiment. Vasosan P is remarkable for good organoleptic properties. It is effective in treating patients with type IIa hyperlipoproteinemia and practically has no side effects as cholestyramine.

Content of apo A-I constitute 136 mg/100 ml, of apo A-II--64 mg/100 ml and of apo E--10 mg/100 ml in blood plasma of 20--60 years old men with normal concentration of cholesterol (alpha-CS) in blood. In the patients with hyper-alpha-lipoproteinemia (alpha-CS was above 76 mg per 100 ml) concentrations of apo A-I and apo A-II were distinctly higher (173 and 71 mg per 100 ml, respectively) and that of apo E--was lower (8 mg per 100 ml) as compared with the healthy persons. Under the conditions of hypo-alpha-lipoproteinemia (alpha-CS was below 37 mg per 100 ml) the contents of apo A-I and apo A-II were decreased down to 116 and 50 mg per 100 ml, respectively, and that of apo E--increased up to 12 mg per 100 ml. Concentration of the total fraction of high density lipoproteins (LPHD), LPHD2 and their subfraction LPHD2a and LPHD2b was also distinctly increased in hyper-alpha-lipoproteinemia; it was decreased in hypo-alpha-lipoproteinemia, while the LPHD3 content was slightly altered in blood plasma. The capacity of LPHD to transfer of CS appears to increase in hyper-alpha-lipoproteinemia and to decrease in hypo-alpha-lipoproteinemia. As shown by correlation analysis, metabolism of LPHD3 occurred independently from the other LPHD subfractions.

Rabbit mesenteric lymph contained all the main classes of lipoproteins detected in plasma: chylomicrons (CM), very low density lipoproteins (VLDL), low density lipoproteins (LDL), high density lipoproteins (HDL). The main classes of lipoproteins in lymph were CM and VLDL, whereas LDL and HDL were the main lipoproteins in blood plasma. The heaviest subfractions HDL3 were not observed in mesenteric lymph. Lymph contained only low amount of LDL; molecular mass of lymphatic LDL was lower as compared with the blood plasma lipoproteins. Mesenteric lymph lipoproteins were enriched with triglycerides and contained less cholesterol, phospholipids and protein than the corresponding blood plasma lipoproteins. As distinct from blood plasma lipoproteins, apo E and apoproteins of low molecular mass (apo C?) were not found in lymphatic lipoproteins. Content of Apo-I was much higher in lymphatic VLDL as compared with the blood plasma VLDL. The dissimilarity in patterns and composition between blood plasma and lymphatic lipoproteins indicated that the latter were derived from intestine. Thus, intestine was able to produce CM, VLDL, HDL2 and apparently a small amount of LDL.

The mean cholesterol content in erythrocytes of patients, which are not impaired by hepatic diseases is 1.26 +/- 0.02 X 10-13 g/cell and it is not depended on the plasma cholesterol level.